Cancer-Associated Thrombosis: Updates and Controversies

In this webinar, our speakers Prof. Anna Falanga, Prof. Alok A Khorana, and Prof. Benjamin Brenner talked about the recent updates on cancer-associated thrombosis diagnosis, prevention, and treatment.

They discussed:

• The role of biomarkers in CAT and cancer progression
• Prevention of cancer-associated thrombosis
• Treatment of cancer-associated VTE

Lord Ajay K Kakkar (UK) chaired this event.

Recording and slides are available for our community members.

If you have missed our webinar or want to re-watch it, here are the event recording and our speakers’ slides. Enjoy!

ICTHIC Webinar recording:

Professor Falanga’s presentation:

“The Evolving Role of Biomarkers in CAT and Cancer Progression”

Professor Khorana’s presentation:

“Primary Prevention of Cancer-Associated VTE”

Professor Brenner’s presentation:

“Treatment of Cancer-Associated VTE”

Other webinars

Hidden Threats: Understanding Thrombosis in Unusual Sites

Managing bleeding in cancer: from anticoagulants to artificial intelligence

Management of CAT in the colorectal cancer patient

Updates in Cancer-Associated Thrombosis

Management of CAT: Lung Cancer Focus

Insights and Challenges in Cardio-Oncology

Challenges in the management of fragile CAT patients (older patient population & palliative care)

Long-term treatment & DDI implications in the management of CAT

Updates in cancer-associated thrombosis

What is the profile of the Real-World CAT patient?

CAT management: challenges in different cancer populations

Joint forces: the Patient & the Multi-disciplinary Team working together to improve outcomes in CAT

Clinical insights in CAT to include COVID‐19

Update on Oncology & Thrombosis to include COVID‐19

The Management of Cancer-Associated Thrombosis: Are We at a Crossroad?